Showing posts with label CBCT Systems Market. Show all posts
Showing posts with label CBCT Systems Market. Show all posts

Thursday, August 1, 2019

Insights into CBCT/Cone Beam Imaging Market and it’s growth outlook


Growing awareness of dental healthcare, growth in geriatric population (especially in Japan), increasing prevalence of orthopedic disorders, partnerships/collaborations among key players, growing medical tourism for dental services, improving healthcare infrastructure, and growing disposable incomes in emerging Asian economies (such as China and India) are some of the key  factors fuelling the growth of this market.

The global CBCT/Cone Beam Imaging Market is expected to reach USD 801.2 Million by 2021 from USD 494.4 Million in 2016, at a CAGR of 10.1% during the forecast period (2016-2021)
The growth of this market is primarily driven by the factors such as growing prevelance of dental disorders, increasing demand for the cosmetic dentistry and expanding applications of CBCT. In addition to this, new product launches and approvals, partnerships, agreements and collaborations among market players and are also providing impetus for the growth of this market. Moreover, acceptance of the CBCT systems in breast imaging and untapped emerging economies provide significant growth opportunities in the market. However, high cost of the CBCT systems may hinder the growth of this market during the forecast period.


In this report, the Global CBCT/cone beam imaging market is segmented on the basis of application, patient position, end user and region.
Based on end user, the CBCT/cone beam imaging market is segmented into hospitals, practices and academic and research institutes. The hospital segment is expected to account for the largest share of the CBCT/cone beam imaging market in 2016. However, private practices are expected to grow at highest CAGR during the forecast period. Growing patient preference for treatment in private clinics over hospitals, owing to advantages such as freedom of choosing preferred physicians, quick consultation with doctors, minimum or no hospital stays, and personalized treatment, are some major factors that drive market growth.

Regional Analysis:-
Based on region, the CBCT/cone beam imaging market is segmented into North America, Europe, Asia and Rest of the World (RoW). In 2016, North America is expected to dominate the market, followed by Europe. The dominance of the North American market is due to the rising incidence of dental disorders, increasing expenditure on dental services, high prevalence of ENT disorders, growing number of orthopedic disorders & sports injuries, rising awareness of CBCT systems through conferences and symposia, and presence of a large number of prominent players in this region. On the other hand, Asia is estimated to be the fastest-growing regional segment during the forecast period. The CBCT/cone beam imaging market is highly competitive with the presence of various established as well as emerging players.

Read more: - https://www.marketsandmarkets.com/PressReleases/cone-beam-imaging.asp

Key Players:-
Some of key players in this market include Danaher Corporation (U.S.), Carestream Health, Inc. (a subsidiary of Onex Corporation) (Canada), Planmeca Group (Finland), Vatech Co., Ltd. (South Korea), Dentsply Sirona (U.S.), Cefla S.C. (Italy), J. Morita MFG. Corp (Japan), Asahi Roentgen IND.CO., LTD. (Japan), PreXion Corporation (Japan), and CurveBeam LLC (U.S.).

Friday, February 15, 2019

Key Players in the CBCT/Cone Beam Imaging Market Pursue Product Launches and Product Approvals and Agreements & Collaborations as their Key Growth Strategies.


The CBCT/Cone beam imaging market is highly competitive with the presence of various established as well as emerging players. Some of key players in this market include Danaher Corporation (U.S.), Carestream Health, Inc. (a subsidiary of Onex Corporation) (Canada), Planmeca Group (Finland), Vatech Co., Ltd. (South Korea), Dentsply Sirona (U.S.), Cefla S.C. (Italy), J. Morita MFG. Corp (Japan), Asahi Roentgen IND.CO., LTD. (Japan), PreXion Corporation (Japan), and CurveBeam LLC (U.S.).


Browse 140 market data tables and 34 figures spread through 159 pages and in-depth TOC on “CBCT/Cone Beam Imaging Market ".


Other players in the market include companies such Yoshida Dental Mfg.Co.,Ltd. (Japan), Villa Sistemi Medicali Spa (Italy), Owandy Radiology (France), Hitachi Medical Systems (Japan), GENORAY Co., Ltd. (Korea), Imageworks Corporation (U.S.), and Trident Srl (Italy).

Companies are focusing on organic as well as inorganic growth strategies such as product launches and product approvals; agreements, partnerships, and collaborations; expansion; and acquisitions. Product launches and product approvals accounted for the largest share of the overall growth strategies adopted by market players between 2013 and 2016. Various new and technologically advanced products were launched during this period. For instance, in October 2015, J Morita upgraded its existing Veraviewepocs 3D R100, 3D/Pan/Ceph system with the addition of two new Field of View (FOV) to provide adjustment to maxilla or mandible, thus reducing the overall radiation exposure. Also, in March 2015 SOREDEX launched the SOREDEX Minidose solution, which is a fast and low-dose 3D imaging option for its CRANEX 3Dx. This enabled the company to expand its product offerings in the market. In addition to the product launches, prominent players in this market received product approvals to market their products in the global CBCT/Cone Beam Imaging. Some of the recent product approvals include OnSight 3D Extremity, a cone beam CT (CBCT) system (Carestream Health, Inc.) (September 2016); Planmed Verity CBCT scanner’s MaxScan maxilofacial imaging mode (Planmeca Group) (May 2015); VATECH Brazil received an approval from Agência Nacional de Vigilância Sanitária (ANVISA) for  its PaX-i series, which includes PaX-i, PaX-i3D, and PaX-i3D Green (August 2014), U.S. FDA approval for Planmed Verity Extremity, a cone beam CT scanner (Planmeca Group) (February 2013); Korean FDA approval for its Planmed Verity Extremity Scanner (Planmeca Group) (January 2013).

Request Free Sample  Report :- https://www.marketsandmarkets.com/requestsampleNew.asp?id=226049013 



Such product launches and approvals help companies to enhance their product offerings and leverage the growth opportunities in this market. Key players who adopted this growth strategy include. Carestream Health Inc. (Canada), Danaher Corporation (U.S.), Planmeca Group (Finland), Dentsply Sirona (U.S.), Vatech Co,. Ltd. (South Korea), Cefla S.C. (Italy), J. MORITA MFG. CORP. (Japan), Curve Beam LLC (U.S.), and PreXion Corporation (Japan).

Antibody Therapeutics Market : Driven by Advances in Biologics and Expanding Clinical Applications

The global antibody therapeutics market is projected to grow from USD 311.2 billion in 2026 to USD 597.1 billion by 2035, at a CAGR of 7.5...